MDL-4101

N/A

Report date: 2025/02/27 16:27:37

NME

Base Information

Drug NameMDL-4101

Drug Alias NameMDL-4101

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionBromodomain-containing protein 4 inhibitors

TargetsBromodomain-containing protein 4

Therapy Area/IndicationsThyroid Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusClinical

Highest Status in ChinaN/A

Originator CompaniesModel Medicines Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsThyroid Neoplasms

Inactive IndicationsN/A

ATC CodeN/A